Canopy Growth (TSE:WEED – Free Report) had its price objective decreased by ATB Capital from C$4.00 to C$3.20 in a research note published on Monday morning,BayStreet.CA reports. ATB Capital currently has an underperform rating on the stock.
Separately, Canaccord Genuity Group decreased their price objective on shares of Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating for the company in a research note on Monday. Four analysts have rated the stock with a sell rating and one has assigned a hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of C$5.40.
Check Out Our Latest Stock Report on Canopy Growth
Canopy Growth Stock Performance
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Articles
- Five stocks we like better than Canopy Growth
- What is the Shanghai Stock Exchange Composite Index?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- The 3 Best Fintech Stocks to Buy Now
- Inflation Persists, But So Do Stock Opportunities: Rally On
- What is the S&P 500 and How It is Distinct from Other Indexes
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.